CLINTERVENTIONAL Trial: Impact of Clinical Consultations and Audiovisual Tools in Interventional Radiology
Launched by MAIMÓNIDES BIOMEDICAL RESEARCH INSTITUTE OF CÓRDOBA · Jul 13, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The CLINTERVENTIONAL Trial is a study designed to see if having a consultation with a doctor and watching informative videos before certain medical procedures can help patients better understand what to expect. The trial focuses on patients who are going to have specific vascular and interventional radiology procedures, such as catheter placements or biopsies. To participate, patients should be between the ages of 65 and 74 and not have certain conditions that would prevent their involvement, such as being pregnant or needing urgent care.
In this trial, patients will be randomly placed into two groups. One group will receive information about their procedure from their doctor, while the other group will meet with a specialist after watching educational videos. All participants will fill out questionnaires to share how well they understood the information, how satisfied they felt with what they were told, and how anxious they were about the procedure. The goal is to find out if the added consultations and videos can improve patient understanding and satisfaction, while also reducing anxiety before the procedures. This study is important as it may help improve how doctors communicate with patients in the future.
Gender
ALL
Eligibility criteria
- • To be eligible, each patient must meet one of the inclusion criteria and none of the exclusion criteria.
- Inclusion Criteria:
- • Patients who are going to undergo one of the following elective vascular interventional procedures: tunneled cuffed catheter placement, fistulography and endovascular treatment of hemodialysis arteriovenous fistulas, vascular recanalization procedures and vascular embolization procedures.
- • Patients undergoing one of the following elective nonvascular interventional procedures: image-guided percutaneous biopsies, percutaneous fluid and abscess drainage, percutaneous transhepatic biliary drainage and percutaneous nephrostomy.
- Exclusion Criteria:
- • Patients under 18 years of age.
- • Patients who require the participation of a third party for informed consent.
- • Pregnant patients.
- • Patients undergoing urgent interventional procedures.
- • Patients with allergy or intolerance to mepivacaine, tramadol, midazolam or fentanyl.
- • Patients who do not understand and speak Spanish properly.
- • Patients with deafness or blindness.
About Maimónides Biomedical Research Institute Of Córdoba
The Maimónides Biomedical Research Institute of Córdoba is a leading research organization dedicated to advancing biomedical science through innovative clinical trials and translational research. Located in Córdoba, Spain, the institute focuses on a multidisciplinary approach to address pressing health challenges, fostering collaboration among researchers, clinicians, and industry partners. Its commitment to excellence in research is complemented by state-of-the-art facilities and a robust ethical framework, ensuring the highest standards of scientific integrity and patient safety. By prioritizing cutting-edge research and the development of novel therapeutic strategies, the Maimónides Biomedical Research Institute aims to contribute significantly to the improvement of global health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Córdoba, , Spain
Patients applied
Trial Officials
Pedro Blas García Jurado, MD
Principal Investigator
Reina Sofia University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials